A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease
Clinical trial NCT07113262 · RECRUITING
Trial details
- NCT number
- NCT07113262
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2026-12-31
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.